AAMU
TWST icon

AEGON Asset Management (UK)’s Twist Bioscience TWST Stock Holding History

AEGON Asset Management (UK)’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-170,609
Closed -$5.84M – 152
2024
Q1 		$5.84M Sell
170,609
-154,369
-48% -$5.57M 0.09% 104
2023
Q4 		$12M Buy
+324,978
New +$7.51M 0.19% 91
2023
Q2 		$6.72M Hold
328,551
– – 0.11% 103
2023
Q1 		$4.95M Buy
+328,551
New +$7.26M 0.09% 109

Other funds holding TWST

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AEGON Asset Management (UK)'s TWST Position: Q2 2024 in Review

AEGON Asset Management (UK) sold out of Twist Bioscience (TWST) in Q2 2024, closing a stake of 170,609 shares — an estimated $5.84M sold.

AEGON Asset Management (UK) first reported a position in TWST in Q1 2023 and held it in 4 quarters. The position peaked at $12M in Q4 2023. 262 funds tracked by Wall St. Rank hold TWST as of Q2 2024.

  • AEGON Asset Management (UK) reported no remaining Twist Bioscience position as of Q2 2024 after selling out during the quarter.
  • AEGON Asset Management (UK) sold 170,609 Twist Bioscience shares in Q2 2024, an estimated $5.84M.
  • AEGON Asset Management (UK) first reported a position in Twist Bioscience in Q1 2023 and held it in 4 quarters.
  • AEGON Asset Management (UK)'s Twist Bioscience position peaked at $12M in Q4 2023.
  • 262 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2024.

Based on AEGON Asset Management (UK)'s 13F filing for Q2 2024, filed 30 Jul 2024.